Pharmacology Fundamentals

Loading the Elevenlabs Text to Speech AudioNative Player...

Fundamentals of Pharma

This post will dip into basic facts of how drugs are studied, major definitions within pharmacology, and how a medication eventually makes it to market.

Pharmacokinetics/dynamics

Pharmacokinetic interactions involve the absorption, distribution, metabolism, and excretion of drugs, while pharmacodynamic interactions involve the way a particular medication is influencing different body systems.

  • Pharmacokinetics→movement and modification of medicine inside the body. (Medication: focus)
  • Pharmacodynamics→the effects the medication has on the body. (Body: focus)
    • Medications with a narrow therapeutic index need to be closely monitored to prevent toxicity.
    • Medications with a wider therapeutic index are less dangerous, but can still be toxic.

Drug interactions may occur on both pharmacokinetic and pharmacodynamic levels. 


Nomenclature

Each medication has 3 names, which it receives during different stages on its way to market.

  • Chemical Name (e.g. N-acetyl-para-aminophenol)
  • Generic Name (e.g. Acetaminophen)
  • Trade Name (e.g. Tylenol)

Drug Development Stages

There are three main stages of drug development and four phases of the last stage, which is clinical trials.

  • discovery → The process of finding new drugs or compounds with potential therapeutic effects.
    • preclinical → Testing on cells and animals to assess a drug's safety and efficacy before human trials.
    • clinical trials → Relating to the observation and treatment of actual patients rather than theoretical or laboratory studies.
      • Phase I: Safety → Determining the safety of a drug in a small group of healthy individuals.
      • Phase II: Efficacy→Determining if the drug has the desired effect in patients with the condition being treated.
      • Phase III: Approval→Phase III clinical trials to assess the drug's effectiveness, safety, and appropriate dosage for FDA approval, comparing to current options.
      • Phase IV: Long Term→Long-term safety and efficacy studies in a larger patient population.

It can often cost millions in filing fees, tens of millions to complete research, and decades of development before a drug finally makes it to a consumer.